Format

Send to

Choose Destination
Nat Rev Immunol. 2011 May;11(5):330-42. doi: 10.1038/nri2970.

Harnessing the biology of IL-7 for therapeutic application.

Author information

1
Immunology Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA. cm35c@nih.gov

Abstract

Interleukin-7 (IL-7) is required for T cell development and for maintaining and restoring homeostasis of mature T cells. IL-7 is a limiting resource under normal conditions, but it accumulates during lymphopaenia, leading to increased T cell proliferation. The administration of recombinant human IL-7 to normal or lymphopenic mice, non-human primates and humans results in widespread T cell proliferation, increased T cell numbers, modulation of peripheral T cell subsets and increased T cell receptor repertoire diversity. These effects raise the prospect that IL-7 could mediate therapeutic benefits in several clinical settings. This Review summarizes the biology of IL-7 and the results of its clinical use that are available so far to provide a perspective on the opportunities for clinical application of this cytokine.

PMID:
21508983
DOI:
10.1038/nri2970
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center